Affimed N.V.

Affimed N.V.: Proprietary ROCK® platform enabling generation of multi-specific antibodies is basis for its collaboration with Genentech ($96M upfront / $5B potential) to develop NK-cell engager-based therapeutics. Pipeline includes NK cell engager AFM13 (CD30/CD16A) to enter Ph 2 registration study in CD30-positive PTCL and an investigator-sponsored study by MDACC of AFM13 combined with allogeneic NK cells in relapsed/refractory CD30-positive lymphoma. IND cleared for AFM24, the company’s innate cell engager that targets EGFR-expressing solid tumors.

Sector/Industry:

Healthcare/Biotechnology

Characteristics:

Based in...

Europe, USA

Clinical Stage

Phase l or ll

Disease Space

Hematology, Immuno-Oncology, Oncology

Finance

Pre-Revenues

Industry

Biotechnology

Listing

Public, USA

Market Cap

1B +

Therapeutic Modalities

Antibodies, Platform Technology

Website:

http://www.affimed.com

Profiles:

Address:

Im Neuenheimer Feld 582
Heidelberg, Baden-Wurttemberg 69120
Germany

Presentation:

Please reach out to Solebury Trout to request a presentation

More info:

Send Message to Request Information

My account:

Company Participants at Solebury Trout Corporate Access 1x1 Calls - Week of April 13

Adi Hoess, Ph.D., Chief Executive Officer
Gregory Gin, Head of Investor Relations

Lead Programs

AFM13

Disease Target CD30 Immune Cell Target CD16A

Indication	Phase
Hodgkin lymphoma + PD-1	1
Hodgkin lymphoma	2
Hodgkin lymphoma + adoptive NK cells	Pre-clinical
CD30-positive lymphoma	2

AFM24

Disease Target EGFRwt Immune Cell Target CD16A

Indication	Phase
Solid tumors	Pre-clinical

Top 10 Holders of Affimed N.V.

Institution	OS (%)	Position	Mkt Val ($MM)	Source	Filing Date
NEA Management Co.	8.03	6,126,488	63.29	13F	12/31/20
Point72 Asset Management LP	7.39	5,635,500	58.21	Stakes	1/27/21
683 Capital Management LLC	5.63	4,289,712	44.31	13F	12/31/20
BlackRock Fund Advisors	4.88	3,723,746	38.47	13F	12/31/20
Citadel LP	4.54	3,459,116	35.73	13F	12/31/20
Point72 Asset Management LP (Old)	4.03	3,075,000	31.76	13F	12/31/20
FundLogic SASU	3.50	2,668,255	27.56	13F	12/31/20
Millennium Management LLC	2.96	2,255,617	23.30	Stakes	12/31/20
Morgan Stanley Capital Services LLC	2.50	1,905,304	19.68	13F	12/31/20
Acadian Asset Management LLC	2.43	1,852,602	19.14	13F	12/31/20

Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...

Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.